-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Agilon Health, Raises Price Target to $3.5

Benzinga·02/26/2025 17:17:05
Listen to the news
RBC Capital analyst Sean Dodge maintains Agilon Health (NYSE:AGL) with a Outperform and raises the price target from $3 to $3.5.